Wuhan Keqian Biology Co Ltd Cash Flow Quality Index
Wuhan Keqian Biology Co Ltd cash flow quality index. Wuhan Keqian Biology Co Ltd (688526) has a Cash Flow Quality Index of 1.48x as of September 2025. Operating cash flow of CN¥174.36 Million exceeds net income of CN¥117.90 Million, indicating high earnings quality where cash backs reported profits. See 688526 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Wuhan Keqian Biology Co Ltd (2016–2024)
Cash flow quality index of Wuhan Keqian Biology Co Ltd from 2016 to 2024. Historical Cash Flow Quality Index for Wuhan Keqian Biology Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 688526 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Wuhan Keqian Biology Co Ltd Cash Flow Quality Index by Year (2016–2024)
Wuhan Keqian Biology Co Ltd cash flow quality index by year from 2016 to 2024. Year-by-year earnings quality comparison for Wuhan Keqian Biology Co Ltd. For the full cash flow conversion analysis, see how efficiently does Wuhan Keqian Biology Co Ltd generate cash.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.03x | CN¥392.68 Million | CN¥381.49 Million | ▼ -24.3% |
| 2023 | 1.36x | CN¥538.03 Million | CN¥395.93 Million | ▲ +31.2% |
| 2022 | 1.04x | CN¥423.71 Million | CN¥409.15 Million | ▲ +11.2% |
| 2021 | 0.93x | CN¥531.27 Million | CN¥570.64 Million | ▲ +4.2% |
| 2020 | 0.89x | CN¥400.14 Million | CN¥447.80 Million | ▲ +40.0% |
| 2019 | 0.64x | CN¥154.89 Million | CN¥242.64 Million | ▼ -29.4% |
| 2018 | 0.90x | CN¥351.83 Million | CN¥388.91 Million | ▼ -14.2% |
| 2017 | 1.05x | CN¥337.61 Million | CN¥320.31 Million | ▼ -11.1% |
| 2016 | 1.19x | CN¥220.69 Million | CN¥186.17 Million | — |